These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Treatment of systemic sclerosis]. van den Hoogen FH Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640 [TBL] [Abstract][Full Text] [Related]
27. A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset. Derk CT; Huaman G; Jimenez SA Br J Dermatol; 2008 May; 158(5):1063-8. PubMed ID: 18284395 [TBL] [Abstract][Full Text] [Related]
28. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis. Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158 [TBL] [Abstract][Full Text] [Related]
29. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study. Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632 [TBL] [Abstract][Full Text] [Related]
30. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033 [TBL] [Abstract][Full Text] [Related]
32. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases. Tio H; van Wijk L; de Haan E Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327 [No Abstract] [Full Text] [Related]
33. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)]. Helmke K; Velcovsky HG; Federlin K Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704 [TBL] [Abstract][Full Text] [Related]
34. Treatment of systemic sclerosis. Medsger TA Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135 [TBL] [Abstract][Full Text] [Related]
35. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Steen VD; Medsger TA Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093 [TBL] [Abstract][Full Text] [Related]
36. The current treatment of scleroderma. Oliver GF; Winkelmann RK Drugs; 1989 Jan; 37(1):87-96. PubMed ID: 2651089 [TBL] [Abstract][Full Text] [Related]
37. [D-penicillamine: an outdated cure for systemic scleroderma?]. Marie I; Lévesque H; Courtois H Rev Med Interne; 1999 Dec; 20(12):1077-81. PubMed ID: 10635068 [No Abstract] [Full Text] [Related]
38. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment. Bluestone R; Grahame R; Holloway V; Holt PJ Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411 [No Abstract] [Full Text] [Related]
39. Treating systemic sclerosis in 2001. Mouthon L; Agard C Joint Bone Spine; 2001 Oct; 68(5):393-402. PubMed ID: 11707005 [TBL] [Abstract][Full Text] [Related]